2024-08-052211.36 MB15页7
2024-08-042211.75 MB24页5
2024-08-012216.6 MB24页26
2024-07-312211.5 MB20页2
2024-07-3122110.72 MB50页4
2024-07-26221684.09 KB16页13
2024-07-252215.36 MB20页27
2024-07-2222110.15 MB118页2
2024-07-202213.27 MB27页20
2024-07-012212.59 MB31页19
2024-06-1822119.16 MB75页13
2024-06-142215.82 MB185页24
2024-06-132215.92 MB84页13
2024-05-18221401.63 KB27页30
2024-05-1122113.28 MB122页18
2024-05-092213.71 MB35页24
2024-05-032211.32 MB24页30
2024-03-2122116.37 MB31页32
2024-02-072214.65 MB36页8
2024-01-022212.35 MB69页13
![医药生物-合成生物学系列报告：政策梳理、投资框架与标的更新-政策自上而下鼓励支持，下游企业布局多点开花-招商证券[许菲菲,梁广楷,焦玉鹏]-20240728【15页】](http://www.bgcaijingpro.com/assets/images/load.png)
